Qkine
PrivateLast Round
VC Round
Mar 21, 2025
Total Funding Raised
$5.12M
Company Overview
Qkine operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a VC Round in March 2025.
Qkine is a biotechnology company that manufactures high-purity, animal-free growth factors, cytokines, and other complex proteins for life science applications, including stem cell and organoid culture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qkine Comparables
Compare Qkine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ORF Genetics | 79% | |
| ProSpec-Tany TechnoGene | 79% | |
| Proteintech Group | 78% |
For institutional investors. Book with your work email.
Qkine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 21, 2025 | ||||
| Early Funding | Sep 2, 2023 | ||||
| Debt | Dec 19, 2022 | ||||
| VC Round | Dec 15, 2022 | ||||
| Series A | Jun 8, 2020 | ||||
Seed | Jun 3, 2019 |
For institutional investors. Book with your work email.
Qkine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Debt |
| EverQuest Capital Partners | Early Funding |
| o2h ventures | VC Round |
| CPI Enterprises | Early Funding |
| Cambridge Enterprise | Seed, Series A |
| Downing Ventures | VC Round |
| EMV Capital | Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
Launched QkPlate (C), pre-prepared dried vitronectin-coated plates.
- Mar 23, 2026
Developing QkPlate (C) human vitronectin coated plates.
For institutional investors. Book with your work email.
Qkine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Qkine's valuation, stock price, and market status.
Is Qkine a public or private company?
Qkine is a private company.
What is the current stock price of Qkine?
Qkine is a private company, so its shares have no public market price. Caplight tracks Qkine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qkine worth (valuation)?
Valuation information for Qkine is not publicly available.
Can I buy Qkine stock?
Qkine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qkine's last funding round?
Qkine's most recent funding round was VC Round on March 21, 2025.
Who are the main investors in Qkine?
Key investors in Qkine include Cambridge Enterprise, Downing Ventures, Parkwalk Advisors.
Will Qkine IPO soon?
No public IPO plans have been announced for Qkine.
How can I track Qkine secondary market activity?
Caplight tracks bids, offers, and trades in Qkine's shares on secondary markets.